TNF alpha Antikörper (AA 115-130)
-
- Target Alle TNF alpha Antikörper anzeigen
- TNF alpha (Tumor Necrosis Factor alpha (TNF alpha))
-
Bindungsspezifität
- AA 115-130
-
Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser TNF alpha Antikörper ist unkonjugiert
-
Applikation
- Flow Cytometry (FACS), Immunohistochemistry (Frozen Sections) (IHC (fro))
- Spezifität
- This antibody reacts with TNFa.
- Aufreinigung
- Concentrated.
- Immunogen
- Synthetic TNF-alpha 115-130 hexadecapeptide linked to carrier protein.
- Klon
- B428
- Isotyp
- IgG1 kappa
- Top Product
- Discover our top product TNF alpha Primärantikörper
-
-
- Applikationshinweise
-
Immunohistochemistry: 1:50-1:100
ELISA 1:500 -1:1000 (this antibody is not purified and can not be used to coat ELISA plates) .
Staining Procedure: This antibody can be used on frozen and formalin-fixed, paraffin-embedded tissue sections. Prolonged fixation in buffered formalin can destroy the epitope. The antibody may be used at a dilution of 1:50-1:100 in IHC. It is recommended that this product be used on frozen tissue sections or specimens. The optimal conditions should be determined by the individual laboratory. - Kommentare
-
Cellular Localization: cytoplasmic and extracellular.
Recommended Positive Control: Prostate cancer - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 0.3 mg/ml.
- Buffer
- 20 mM tris-borate, 150 mM Sodium Chloride, dialyzed media RPMI 1640/D-MEM containing fetal bovine serum, BMC-6 carrier polysaccharides, carrier protein, pH 7.5
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C
-
- Target
- TNF alpha (Tumor Necrosis Factor alpha (TNF alpha))
- Andere Bezeichnung
- Tumor Necrosis Factor Alpha (TNF alpha Produkte)
- Molekulargewicht
- 17 kDa
- Gen-ID
- 7124
- Pathways
- NF-kappaB Signalweg, Apoptose, Caspase Kaskade in der Apoptose, TLR Signalweg, Cellular Response to Molecule of Bacterial Origin, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, Positive Regulation of Endopeptidase Activity, Hepatitis C, Protein targeting to Nucleus, Inflammasome
-